|Salary:||£36,333 to £40,745 per annum, Grade: I / 2 (a)|
|Placed On:||21st March 2023|
|Closes:||4th April 2023|
You will be a post-doctoral researcher to drive forward a translational program of ocular gene therapy for age-related macular degeneration (AMD) at the University of Bristol, working with Dr Jian Liu and Prof Andrew Dick.
You will lead the project and undertake cell-based studies, molecular and transcriptomic assessments, and viral-based gene delivery for therapeutic evaluation. You will be supervised and supported in post by the PI and co-Is and will join the wider academic community of the Ophthalmology research group at the University of Bristol which has diverse interests in ocular immunology and clinical links to the Bristol Eye Hospital.
What will you be doing?
You should apply if
Contract type: Open ended with funding until 24/04/25
Shift pattern: 35 per week / 1FTE
This advert will close at 23:59 GMT on 04/04/2023
For any informal enquiries please contact Jian Liu: firstname.lastname@example.org or Andrew Dick email@example.com
We recently launched our strategy to 2030 tying together our mission, vision and values.
The University of Bristol aims to be a place where everyone feels able to be themselves and do their best in an inclusive working environment where all colleagues can thrive and reach their full potential. We want to attract, develop, and retain individuals with different experiences, backgrounds and perspectives – particularly people of colour, LGBT+ and disabled people - because diversity of people and ideas remains integral to our excellence as a global civic institution.
Type / Role: